Skip to main content
. Author manuscript; available in PMC: 2011 Oct 17.
Published in final edited form as: Menopause. 2011 Mar;18(3):279–284. doi: 10.1097/gme.0b013e3181f2ea2e

Table 2.

Changes in depression and hot flash scores from baseline to end point

variable change from baseline to end of study n* Mean Pre- Treatment Score Mean Post- Treatment Score Mean Change Score Standard Deviation of Mean Change Score Median of the Change Score IQR of the Change Score pvalue
MADRS 20 24.2 ± 3.9 10.7 ± 8.5 13.5 7.9 13.5 7.0 <0.0001*
Hot Flash Scores: 24-hour score 15 9.0 ± 10.3 2.5 ± 4.0 5.1 9.70 2.1 5.4 0.02*
Daytime hot flash score 15 4.3 ± 4.8 1.8 ± 3.6 2.0 5.0 0.9 2.9 0.05*
Nighttime hot flash score 15 4.6 ± 5.5 0.7 ± 0.8 3.2 4.9 1.1 3.1 0.002*
HFRDIS 15 36.9 ± 27.7 14.1 ± 24.2 22.9 27.5 20.0 44.0 0.37
*

indicates significant change from baseline to endpoint (with alpha ≤ 0.05)

N=20, number of participants who started omega-3 fatty acids after the one-week placebo lead in N=15, number of participants who had hot flashes at baseline and could be included in the hot flash analyses